Viewing Study NCT01254227


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-11 @ 1:19 AM
Study NCT ID: NCT01254227
Status: COMPLETED
Last Update Posted: 2021-07-26
First Post: 2010-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2013-11
Primary Completion Date Type: ACTUAL
Completion Date: 2013-11
Completion Date Type: ACTUAL
First Submit Date: 2010-09-21
First Submit QC Date: None
Study First Post Date: 2010-12-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-04-29
Results First Submit QC Date: None
Results First Post Date: 2021-06-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-23
Last Update Post Date: 2021-07-26
Last Update Post Date Type: ACTUAL